Immediate Impact
51 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
Works of Masaki Shimoji being referenced
KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments
2021 Standout
EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Masaki Shimoji | 762 | 662 | 418 | 37 | 1.1k | |
| Toshiki Takemoto | 608 | 518 | 366 | 39 | 924 | |
| Remy B. Verheijen | 772 | 618 | 519 | 50 | 1.3k | |
| Takuro Kometani | 589 | 616 | 551 | 43 | 1.2k | |
| Dana Ghiorghiu | 911 | 794 | 487 | 35 | 1.3k | |
| Gonzalo Recondo | 553 | 616 | 361 | 52 | 1.1k | |
| Ichiro Kawada | 659 | 567 | 511 | 54 | 1.1k | |
| Toshio Fujino | 550 | 407 | 386 | 52 | 935 | |
| Qi Li | 564 | 537 | 525 | 27 | 1.0k | |
| Pang‐Dian Fan | 667 | 604 | 587 | 25 | 1.2k | |
| Roberta Caputo | 633 | 773 | 587 | 26 | 1.3k |
All Works
Loading papers...